Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events-Reference-Cited by-同舟云学术

Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events

Published:2016-07-01 Issue:4 Volume:1 Page:425
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Bonaca Marc P.¹,Bhatt Deepak L.¹,Oude Ophuis Ton²,Steg P. Gabriel³,Storey Robert⁴,Cohen Marc⁵,Kuder Julia¹,Im Kyungah¹,Magnani Giulia¹,Budaj Andrzej⁶,Theroux Pierre⁷,Hamm Christian⁸,Špinar Jindrich⁹,Kiss Robert G.¹⁰,Dalby Anthony J.¹¹,Medina Felix A.¹²,Kontny Frederic¹³,Aylward Philip E.¹⁴,Jensen Eva C.¹⁵,Held Peter¹⁵,Braunwald Eugene¹,Sabatine Marc S.¹⁶

Affiliation:

1. TIMI Study Group, Brigham and Women’s Hospital Heart and Vascular Center, Boston, Massachusetts

2. Department of Cardiology, CWZ Hospital, Nijmegen, the Netherlands

3. Département Hospitalo Universitaire FIRE, AP-HP, Hôpital Bichat, Paris, France4Université Paris–Diderot, Sorbonne Paris Cité, Paris, France

4. Department of Cardiovascular Science, University of Sheffield, Sheffield, England

5. Cardiovascular Division, Newark Beth Israel Medical Center, Rutgers–New Jersey Medical School, Newark, New Jersey

6. Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland

7. Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada

8. Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany10University of Giessen, Giessen, Hesse, Germany

9. Internal Cardiology Department, University Hospital and Medical Faculty, Brno, Czech Republic

10. Department of Cardiology, Military Hospital, Budapest, Hungary

11. South African Cardiology Clinical Trials Group, Milpark Hospital, Johannesburg, South Africa

12. Departamento de Clínicas Médicas, Hospital Nacional Cayetano Heredia, San Martin de Porres, Lima, Peru

13. Department of Cardiology, Stavanger University Hospital, Stavanger, Norway

14. South Australian Health and Medical Research Institute, Flinders University, Adelaide, Australia

15. AstraZeneca Research and Development, Mölndal, Sweden

16. TIMI Study Group, Brigham and Women’s Hospital Heart and Vascular Center, Boston, Massachusetts18Deputy Editor, JAMA Cardiology

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to Secondary Prevention Measures after Acute Myocardial Infarction and Its Impact on Patient Outcome—A Nationwide Perspective;Journal of Clinical Medicine;2024-08-22

2. The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury;Phytomedicine;2024-07

3. Remote intensive management to improve antiplatelet adherence in acute myocardial infarction: a secondary analysis of the randomized controlled IMMACULATE trial;Journal of Thrombosis and Thrombolysis;2024-02-01

4. Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention;JACC: Cardiovascular Interventions;2023-10

5. Ticagrelor-Induced Dyspnea;JACC: Cardiovascular Interventions;2023-10